Arbe Robotics Ltd (ARBE) concluded trading on Thursday at a closing price of $1.08, with 0.45 million shares of worth about $0.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.40% during that period and on April 17, 2025 the price saw a gain of about 2.86%. Currently the company’s common shares owned by public are about 85.75M shares, out of which, 72.90M shares are available for trading.
Stock saw a price change of 3.85% in past 5 days and over the past one month there was a price change of -20.59%. Year-to-date (YTD), ARBE shares are showing a performance of -41.94% which decreased to -42.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.85 but also hit the highest price of $5.09 during that period. The average intraday trading volume for Arbe Robotics Ltd shares is 4.78 million. The stock is currently trading -0.90% below its 20-day simple moving average (SMA20), while that difference is down -31.96% for SMA50 and it goes to -44.85% lower than SMA200.
Arbe Robotics Ltd (NASDAQ: ARBE) currently have 85.75M outstanding shares and institutions hold larger chunk of about 23.36% of that.
The stock has a current market capitalization of $113.57M and its 3Y-monthly beta is at 0.33. It has posted earnings per share of -$0.62 in the same period. It has Quick Ratio of 1.58 while making debt-to-equity ratio of 1.45. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARBE, volatility over the week remained 6.26% while standing at 8.70% over the month.
Stock’s fiscal year EPS is expected to rise by 39.34% while it is estimated to increase by 4.05% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Canaccord Genuity on April 01, 2025 offering a Buy rating for the stock and assigned a target price of $1.75 to it. On November 29, 2024, Maxim Group Reiterated their recommendations, while on February 04, 2022, Maxim Group Initiated their ratings for the stock with a price target of $14. Stock get an Outperform rating from Cowen on December 08, 2021.
